FLT3-ITD and NPM1 mutations were previously reported to be associated with specific differential gene expression profiles in AML (Figure S1) [25,52]; however the influence of these aberrations on splicing has not been studied thus far. The gene discussed is NPM1; the disease is acute myeloid leukemia.